Educational information, not medical advice — ask your doctor or midwife.
Aceituno is the bitter bark of Simarouba glauca, a tree also called the paradise tree. It is used in Latin American folk practice as a gut and fever remedy. The seeds press into a mild cooking oil that is eaten as ordinary food.
The tree grows in Mexico, Central America, Cuba and northern South America. The bark is stripped, dried and brewed. You may also see capsules, tinctures and leaf powder sold online.
Here is the honest verdict. Human evidence for the bark itself is thin and dated. One purified compound from the tree was tested in people for amoebic dysentery many decades ago, with some success.
That old work does not transfer to a bag of bark or a capsule. Long traditional use is not proof that a remedy works. It is also not proof that it is safe.
No one has shown, in good human trials, how aceituno bark acts in the body.
The bark holds bitter compounds called quassinoids. In test tubes, some of these slow the growth of Entamoeba histolytica, the parasite behind amoebic dysentery. In animal studies, one of them, glaucarubin, reduced that infection.
That is the strongest thread of science here. Even so, a lab dish is not a human gut. The dose and purity of a home-brewed bark tea are not known.
In cell studies, quassinoids from the tree also kill some cancer cells. This is very early work. It does not mean the bark treats cancer in people, and it should never replace cancer care.
The bark is intensely bitter. Bitter plants can trigger saliva and stomach juices, which may explain its old use as a stomach tonic. That effect is plausible but not proven for this plant.
At higher amounts the same compounds irritate the stomach and cause vomiting. So the line between a traditional dose and an unpleasant one appears to be narrow.
Aceituno reaches buyers in a few forms. Each one behaves differently.
Dried bark chips or powder, brewed as a tea or decoction.
Tinctures, where the bark is soaked in alcohol.
Capsules of powdered bark or leaf.
Leaf powder, sold mainly from Indian growers, where the tree was planted for its oil.
Aceituno seed oil, sold as a cooking oil or a soap and cosmetic base. This is a food product, not the herbal remedy.
Few of these products are tested for strength or purity. Labels rarely say how much quassinoid is present. Bark and leaf are not the same material, and the labels do not always make that clear.
Bitter simarouba bark has a long record in Latin American and Caribbean folk medicine.
It was brewed for dysentery, loose stools, fever and worms. Healers also used it as a bitter tonic for poor appetite. Washes of the bark were put on skin sores.
In the 1700s, bark from simarouba trees was shipped to Europe and used for dysentery outbreaks. Much of that trade bark came from the related tree Simarouba amara.
In the mid 1900s, chemists isolated glaucarubin and tried it in patients with amoebic dysentery. Safer and more reliable drugs later replaced it.
The tree carries a second history as a crop. It was planted in India from the 1960s for its seed oil and shade. That planting is farming, not medicine.
Stop taking it and see a doctor if any of these happen.
Vomiting that will not settle, or you cannot keep fluids down.
Blood or mucus in your stool.
Fever lasting more than two days, or a fever after travel to a malaria area.
Severe stomach pain.
Yellowing of your skin or eyes, or dark urine.
Signs of dehydration: dizziness, very little urine, a dry mouth.
Get urgent care for a child who has swallowed the bark or tincture.
In the United States, aceituno bark is sold as a dietary supplement and is not reviewed for safety or effect before sale. In the UK and EU it is not an approved herbal medicine, though the seed oil may be sold as a food or cosmetic ingredient. Rules differ by country, so check your own.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.